Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder

American Family Physician

Volumn 79, Issue 8, 2009, Pages 657-665

  Rader, Robert ^a   Mccauley, Larry ^b   Callen, Erin C ^b  

^a St Anthony Fam Practice Residency   (United States)

^b SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; DOPAMINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; NORADRENALIN; PLACEBO; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CENTRAL STIMULANT AGENT;

ABDOMINAL PAIN; AGITATION; ANOREXIA; ANTICHOLINERGIC EFFECT; ANXIETY; ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; CHILD BEHAVIOR CHECKLIST; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DROWSINESS; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; ELECTROCARDIOGRAPHY; FATIGUE; FOOD AND DRUG ADMINISTRATION; GROWTH DISORDER; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; INSOMNIA; LOW DRUG DOSE; MORNING DOSAGE; NAUSEA; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOTHERAPY; PULSE RATE; QUALITY OF LIFE; RATING SCALE; REVIEW; SCREENING TEST; SEIZURE; SIDE EFFECT; SKIN IRRITATION; STOMACH PAIN; SUDDEN DEATH; TACHYCARDIA; TIC; VOMITING; WEIGHT REDUCTION; XEROSTOMIA; ADOLESCENT; CHILD; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; HUMANS; NEUROTRANSMITTER AGENTS;

EID: 66149087716     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Krull KR. Evaluation and diagnosis of attention deficit hyperactivity disorder in children. http://www.uptodate.com (subscription required). Accessed December 15, 2008.
2. St Sauver JL, Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Early life risk factors for attention-deficit/hyperactivity disorder: a population-based cohort study. Mayo Clin Proc. 2004;79(9):1124-1131. (Pubitemid 39129474)
3. Reiff MI, Tippins S. ADHD: A Complete and Authoritative Guide. Elk Grove Village, Ill.: American Academy of Pediatrics; 2004.
4. Dopheide JA. ADHD Part 1: Current status, diagnosis, etiology/ pathophysiology. American Pharmaceutical Association 148th Annual Meeting. March 16-20, 2001; San Francisco, Calif. http://www.medscape.com/viewarticle/418518. Accessed December 15, 2008.
5. Quist JF, Kennedy JL. Genetics of childhoood disorders: XXIII. ADHD, part 7: the serotonin system. J Am Acad Child Adolesc Psychiatry. 2001;40(2):253-256. (Pubitemid 32111031)
6. Biederman J, Kwon A, Aleardi M, et al. Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am J Psychiatry. 2005;162(6):1083-1089. (Pubitemid 40770690)
7. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics. 2000;105(5):1158-1170. (Pubitemid 30243801)
8. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(10 suppl):85S-121S.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association;1994:78-85.
10. Pliszka SR, Greenhill LL, Crismon ML, et al. The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactive Disorder. Part II: Tactics. Attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(7):920-927. (Pubitemid 30429925)
11. Castellanos FX. Toward a pathophysiology of attention-deficit/ hyperactivity disorder. Clin Pediatr (Phila). 1997;36(7):381-393. (Pubitemid 27297591)
12. Wolraich ML, Wibbelsman CJ, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115(6):1734-1746. (Pubitemid 43843185)
13. New developments in the treatment of attention-deficit/hyperactivity disorder in primary care. Prim Care Companion J Clin Psychiatry. 2006;8(4):224-233.
14. American Academy of Pediatrics Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108(4):1033-1044.
15. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148(5):564-577.
16. Spencer T, Biederman J, Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am.1999;46(5):915-927. (Pubitemid 29477881)
17. Semrud-Clikeman M, Biederman J, Sprich-Buckminster S, Lehman BK, Faraone SV, Norman D. Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample. J Am Acad Child Adolesc Psychiatry. 1992;31(3):439-448.
18. Nolan EE, Sverd J, Gadow KD, Sprafkin J, Ezor SN. Associated psychopathology in children with both ADHD and chronic tic disorder. J Am Acad Child Adolesc Psychiatry. 1996;35(12):1622-1630. (Pubitemid 26403628)
19. Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs. 2005;19(8):643-655. (Pubitemid 41305982)
20. Smucker WD, Hedayat M. Evaluation and treatment of ADHD. Am Fam Physician. 2001;64(5):817-829.
21. Wolraich ML. Review of AAP ADHD guidelines - evidence-based recommendations for evaluation, diagnosis, and treatment protocol development. http://www.medscape.com/viewarticle/523295-2. Accessed December 15, 2008.
22. Reynolds CR, Kamphaus RW. BASC: Behavior Assessment System for Children: Manual. Circle Pines, Minn.: American Guidance Service, Inc.; 1992.
23. Achenbach TM. Manual for the Child Behavior Checklist. Burlington, Vt.: University of Vermont, Department of Psychiatry; 1991.
24. Achenbach TM. Manual for the Teacher's Report Form. Burlington, Vt.: University of Vermont, Department of Psychiatry; 1991.
25. Conners CK. Conners' Rating Scales - Revised User's Manual. North Tonawanda, NY: Multi Health Systems, Inc.; 1997.
26. DuPaul GJ. Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample. J Clin Child Psychol. 1991;20(3):245-253.
27. Kamphaus RW, Reynolds CR. BASC Monitor for ADHD: Manual and Software Guide. Circle Pines, Minn.: American Guidance Service; 1998.
28. Edelbrock C. Child attention problems scale (unpublished manuscript). Penn State University, University Park, 1978.
29. Ullmann RK, Sleator EK, Sprague RL. A new rating scale for diagnosis and monitoring of ADD children. Psychopharmacol Bull. 1984;20(1):160-164. (Pubitemid 14128891)
30. Barkley RA, Murphy KR. Attention-Deficit/Hyperactivity Disorder: A Clinical Workbook. 2nd ed. New York, NY: Guilford Press; 1998.
31. Dopheide JA. ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients. Am J Health Syst Pharm. 2005;62(14):1502-1509. (Pubitemid 41008867)
32. Rappley MD. Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med. 2005;352(2):165-173. (Pubitemid 40517107)
33. Biederman J, Heiligenstein JH, Faries DE, et al., for the Atomoxetine ADHD Study Group. Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder. Pediatrics. 2002;110(6):e75.
34. Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placeo-controlled study. Am J Psychiatry. 2002;159(11):1896-1901. (Pubitemid 35283256)
35. Greenhill LL, Pliszka S, Dulcan MK, et al., for the American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41(2 suppl):26S-49S.
36. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998;279(14):1100-1107.
37. Faraone SV, Biederman J, Roe C. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol. 2002;22(5):468-473.
38. Lisska MC, Rivkees SA. Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab. 2003;16(5):711-718. (Pubitemid 37259153)
39. Schonwald A. Update: attention deficit/hyperactivity disorder in the primary care office. Curr Opin Pediatr. 2005;17(2):265-274. (Pubitemid 40516112)
40. Barrickman LL, Perry PJ, Allen AJ, et al. Buproprion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995;34(5):649-657.
41. Conners CK, Casat CD, Gualtieri CT, et al. Buproprion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1996;35(10):1314-1321. (Pubitemid 26327705)
42. Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of attention-deficit/hyperactivity disorder. Evidence report/technology assessment no. 11. Rockville, Md.: AHRQ; 1999. AHRQ publication no. 00-E005.
43. Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;38(12):1551-1559.
44. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073- 1086.